Basel, Switzerland

Alexander Lee Satz

This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2019-2020.

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Basel, CH (2019)
  • Schoenenbuch, CH (2020)

Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Alexander Lee Satz

Introduction

Meet Alexander Lee Satz, a brilliant inventor hailing from Basel, Switzerland. With a total of 3 patents to his name, Satz has made significant contributions to the field of pharmaceuticals through his innovative creations.

Latest Patents

Satz's latest patents include groundbreaking inventions such as "Bicyclic quinazolinone derivatives" and "Triaza-spirodecanones as DDR1 inhibitors." These compounds showcase his expertise and creative approach to developing novel solutions in the pharmaceutical industry.

Career Highlights

Having worked at prestigious companies like Hoffmann-La Roche Inc., Satz has accumulated valuable experience and knowledge in the field. His contributions at Hoffmann-La Roche Inc. have played a key role in advancing research and development efforts within the company.

Collaborations

Throughout his career, Satz has had the opportunity to collaborate with esteemed peers such as Bernd Buettelmann and Buelent Kocer. These partnerships have fostered a collaborative and innovative environment, leading to successful projects and patents.

Conclusion

In conclusion, Alexander Lee Satz stands out as a visionary inventor with a passion for pushing the boundaries of pharmaceutical research. His patents and collaborations exemplify his dedication to innovation and his commitment to driving progress in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…